Latest stories on FRNM
FDA Approval Expands Colorectal Cancer Screening Access as Freenome and Abbott Launch SimpleScreen CRC in the U.S.
July 27, 2026
MarketChameleon73 · bullishproduct/pr
Freenome, Inc. (PCSC) files 8-K
SEC 8-K50 · neutralgeneral
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
Business Insider73 · bullishproduct/pr